Terms: = Breast cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
1257 results:
1. circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR-155-5p/FZD5 axis.
He J; Yu K; Liang G; Shen W; Tian H
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23742. PubMed ID: 38780005
[TBL] [Abstract] [Full Text] [Related]
2. Natural History and Prognostic Model of Untreated Papillary Thyroid cancer: A SEER Database Analysis.
Wang D; Yang Y; He Y; Yang H; Yang L
Cancer Control; 2024; 31():10732748241253956. PubMed ID: 38756002
[TBL] [Abstract] [Full Text] [Related]
3. Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer.
Zhang B; Zhang Y; Chang K; Hou N; Fan P; Ji C; Liu L; Wang Z; Li R; Wang Y; Zhang J; Ling R
J Cancer Res Clin Oncol; 2024 May; 150(5):258. PubMed ID: 38753091
[TBL] [Abstract] [Full Text] [Related]
4. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract] [Full Text] [Related]
5. Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing.
Pastuszak K; Sieczczyński M; Dzięgielewska M; Wolniak R; Drewnowska A; Korpal M; Zembrzuska L; Supernat A; Żaczek AJ
Sci Rep; 2024 May; 14(1):11057. PubMed ID: 38744942
[TBL] [Abstract] [Full Text] [Related]
6. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
Ren Y; Feng L; Tan Z; Zhou F; Liu S
Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
[TBL] [Abstract] [Full Text] [Related]
7. Preexisting Diabetes and breast cancer Treatment Among Low-Income Women.
Bekele BB; Lian M; Schmaltz C; Greever-Rice T; Shrestha P; Liu Y
JAMA Netw Open; 2024 May; 7(5):e249548. PubMed ID: 38717774
[TBL] [Abstract] [Full Text] [Related]
8. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer.
Giorello MB; Marks MP; Osinalde TM; Padin MDR; Wernicke A; Calvo JC; Chasseing NA; Vellón L
Cancer Epidemiol; 2024 Jun; 90():102573. PubMed ID: 38692143
[TBL] [Abstract] [Full Text] [Related]
9. Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer.
Chereda H; Leha A; Beißbarth T
Artif Intell Med; 2024 May; 151():102840. PubMed ID: 38658129
[TBL] [Abstract] [Full Text] [Related]
10. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract] [Full Text] [Related]
11. Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
[TBL] [Abstract] [Full Text] [Related]
14. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
16. Exploration of a noninvasive radiomics classifier for breast cancer tumor microenvironment categorization and prognostic outcome prediction.
Han X; Gong Z; Guo Y; Tang W; Wei X
Eur J Radiol; 2024 Jun; 175():111441. PubMed ID: 38537607
[TBL] [Abstract] [Full Text] [Related]
17. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract] [Full Text] [Related]
18. Construction of an oxidative stress-associated genes signature in breast cancer by machine learning algorithms.
Hu D; Qin B; Zhang L; Bu H
J Int Med Res; 2024 Mar; 52(3):3000605241232560. PubMed ID: 38520254
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
Wang M; Wei Z; Kong J; Zhao H
Diagn Pathol; 2024 Mar; 19(1):53. PubMed ID: 38509525
[TBL] [Abstract] [Full Text] [Related]
20. Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
Godina C; Belting M; Vallon-Christersson J; Isaksson K; Bosch A; Jernström H
Sci Rep; 2024 Mar; 14(1):6675. PubMed ID: 38509243
[TBL] [Abstract] [Full Text] [Related]
[Next]
